Activ8 Insights
← All reports
NASDAQ:POET05/15/2026

Night Market Research Short Report on POET

$18.41
Open on report
$6.89
Close on report
-62.57%
% since report

Night Market Research on POET Technologies Inc.


Bottom Line

The allegation. Night Market Research alleges that POET Technologies has systematically misrepresented the status of its commercial partnerships, including with Marvell/Celestial AI, Foxconn, Luxshare, and LITEON, while engineering a circular promotional scheme through the Lumilens purchase order to justify a $400m capital raise.
The company. POET Technologies develops the Optical Interposer, a passive-alignment photonic integration platform targeting high-speed datacenter transceivers, and has promoted imminent commercialization since 2013 while generating only $1.2m in chip revenue since 2018.
The point. With POET trading at approximately 3,700x 2025 revenue and a $4B valuation built on partnerships Night Market Research characterizes as dead or fabricated, the firm believes the stock should trade at a discount to its approximately $430m cash balance, implying roughly $3 per share.

Activ8 Report Assessment

Activ8 evaluates every investigator report across three dimensions: the nature of the thesis, the type of evidence supporting it, and the catalyst for stock repricing. Scores are derived solely from the source report. New to these dimensions? Read our guide.

Thesis Classifies the nature of the investigator’s central claim. Structural/Valuation concerns overpricing or business erosion. Governance covers conflicts of interest, self-dealing, or oversight failures. Fraud/Deception involves deliberate misrepresentation, concealment, or securities violations.
Fraud / DeceptionStructural / ValuationGovernance

Night Market Research documents deliberate misrepresentation of partnership status, including CFO Mika's April 21 interview implying active Celestial AI shipments days before disclosing order cancellation, and a warrant-for-purchase-order structure with Lumilens that the firm characterizes as circular stock promotion rather than genuine commercial demand. The $4B valuation at 3,700x 2025 revenue is characterized as nonsensical for a company with $1.2m in cumulative chip revenue since 2018 and a technology an industry expert called 'a solution looking for a problem.'

Evidence Type Describes the primary type of evidence supporting the thesis. Analytical relies on financial modeling, peer comparisons, or pattern-based inference. Documentary uses SEC filings, court records, or regulatory documents. Primary involves original investigation such as FOIA requests, interviews, site visits, or proprietary research.
AnalyticalDocumentaryPrimary

Night Market Research conducted primary fieldwork at OFC 2026, interviewing executives from seven POET partners, visiting the Toronto headquarters, and speaking with a former senior Rockley Photonics engineer; it also reviewed Singapore corporate filings for Rain Tree Photonics, Accton financial statements, SEC and SEDAR filings, and Zacks analyst reports. Analytical work includes benchmarking POET's IP against Celestial AI's $20m Rockley patent acquisition and modeling Lumilens' implied valuation from Accton's balance sheet carrying value.

Downside Catalyst Indicates whether a specific event could force the market to reprice the stock. Thesis-Only means no identifiable trigger. Pending Catalyst means a likely catalyst exists without an exact date. Specific Event means a concrete, datable event has been identified.
Pending CatalystSpecific Event

Night Market Research identifies the pending $50m Lumilens purchase order fulfillment timeline (engineering samples late 2026, production ramp 2027) as a near-term event likely to expose the agreement as non-binding, and notes POET's unnamed lawsuit disclosure and the $400m capital raise completed on the basis of the Lumilens deal as specific events already in motion that could force repricing.

Not Present: Thesis-Only


How POET Technologies Makes Money

POET Technologies (NASDAQ: POET) develops the Optical Interposer, a passive-alignment photonic integration platform designed to reduce cost and complexity in high-speed datacenter transceiver modules. Originally the semiconductor division of Opel Solar, the company rebranded in 2013 and formally launched the Optical Interposer in 2018. Cumulative chip revenue since 2018 totals $1.2m. POET outsources manufacturing, previously through a joint venture with Sanan IC (Super Photonics Xiamen), which collapsed in November 2024 after Sanan funded only $7m of $25m committed, and now through agreements with Malaysian firms Globetronics and NationGate. The company recently completed a $400m equity raise.


Main Report Evidence

Rain Tree's Financials Expose Lumilens' Technology Platform as Commercially Worthless

Rain Tree Photonics, acquired by Lumilens seven weeks before the $50m POET order was placed, generated only $800k in revenue over three years while its total assets collapsed from $12.7m to $3.2m. Night Market Research draws on Singapore corporate filings to show that none of Rain Tree's marquee partnerships produced volume deployments, attributing the failure to die-shift, warpage, and yield problems inherent in its FOWLP-based photonic architecture. Because the entire Lumilens-POET deal rests on this technology, Night Market Research argues the $50m order and POET's broader commercialization narrative lack a credible technical foundation.

Rain Tree Photonics Financial Deterioration — Singapore Filings 2023–2025

Metric 2023 2024 2025
Annual Revenue$208k$356k
Total Revenue (3-year cumulative)~$800k
Total Assets$12.7m$3.2m

Source: Singapore corporate filings for Rain Tree Photonics, as cited by Night Market Research


Key Allegations

01

Marvell Partnership Dead Years Before Disclosure

Night Market Research reports that Celestial AI's Senior Director of Product Management told them at OFC 2026 that POET has not been discussed internally at Celestial since 2023. CFO Thomas Mika referenced an 'invoice' from Celestial AI in an April 21 interview, implying active near-term shipments; POET disclosed the order cancellation six days later on April 27. Night Market Research believes Mika's characterization was inaccurate and misleading, and that POET's explanation attributing the cancellation to a confidentiality breach does not add up.

02

Seven OFC Partners Describe Dead or Immaterial Relationships

At OFC 2026, Night Market Research spoke to executives from seven POET-listed partners and found unanimous evidence of commercially insignificant or defunct relationships: a Foxconn executive said Foxconn stopped using POET two years ago; two Luxshare product development executives had never heard of POET; an Adtran executive confirmed POET technology is in only one transceiver still in technical testing with no plans to expand; and LITEON's President stated 'LITEON doesn't cooperate with this company' and 'there isn't actual business between us.' Mitsubishi has not issued its own press release on its POET arrangement and is not marketing any POET product.

03

Lumilens Order Structured as Warrant-Funded Circular Promotion

Night Market Research alleges that Lumilens, which has no patents, no publicly announced customers, and revenues of only a few million dollars, received 2.3 million warrants now worth over $30m simply for signing a $50m purchase order with no apparent binding obligation to buy anything. Lumilens CEO Ankur Singla sits on Accton's board of directors, and Accton invested $9m into Lumilens' Series B in April 2025; Accton and Lumilens offices are within a few hundred feet of each other in San Jose. Night Market Research believes Accton's subsidiary GoldiLink is also likely POET's unnamed $5m customer, making the entire arrangement circular.

04

JV Collapse and $3m Unfulfilled Order Signal Commercialization Failure

Sanan IC withdrew from POET's Super Photonics Xiamen joint venture in November 2024 after contributing only $7m of $25m committed, with POET now repaying Sanan $6.5m over five years. A $3m purchase order from Beijing FeiYunYi Technology announced in May 2023 was never fulfilled, and Night Market Research believes the $5m order announced in October 2025 faces similar cancellation risk given POET's refusal to identify the customer and management's avoidance of the topic in public forums.

05

POET Technology Described as Commercial Dead End by Rockley Engineer

A former senior engineer at Rockley Photonics, which POET's own CFO identified as its closest competitor, told Night Market Research that POET's Optical Interposer is 'a solution looking for a problem' and that incumbent silicon photonics and externally modulated laser technologies are 'good enough' to meet hyperscaler needs for the next decade. The engineer stated that the pluggable transceiver market is 'a race to the bottom when it comes to cost' and that POET cannot compete, noting that Intel, Broadcom, and every US vendor exited the business. Night Market Research notes that Celestial AI chose to acquire Rockley's patent portfolio for $20m in October 2024, implying a per-share IP value of roughly $0.15 for POET, rather than invest further in POET despite prior familiarity with the technology.


Disclaimer

The information provided on Activ8Insights.com—including all articles, reports, commentary, and associated content—is intended solely for informational and educational purposes. It does not constitute investment advice, an offer, or a recommendation to buy or sell any securities. All views and opinions presented aim to promote transparency and critical dialogue around activist investing—particularly short activism—and should not be interpreted as personalized financial advice. Investors are solely responsible for their own due diligence and investment decisions, based on publicly available information and their individual financial circumstances. Contributors to or affiliates of Activ8Insights may hold long or short positions in the securities mentioned. These positions may change at any time without notice, and there is no obligation to disclose such changes after publication. Any market data listed is data at the most recent market close. Market data may be delayed or changed after publication on Activ8Insights.com.